Scribd Logo
Upload

Welcome to Scribd!

  • 19 views

    Pharma Data

    Uploaded by

    Gem Emerald
    The Indian pharmaceutical market was worth $6.9 billion in the 12 months ending January 2009, growing at a rate of 9.9%. Cipla held the largest market share of 5.3% while growing at 13.4%, and Ranbaxy was the second largest with a 5% market share and 11.5% growth rate. By 2010, Ranbaxy had become the largest pharmaceutical company in India with revenues of $41.989 billion, followed by Dr. Reddy's Laboratories with $41.622 billion in revenues.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Pharma Data

    Uploaded by

    Gem Emerald
    19 views2 pages
    The Indian pharmaceutical market was worth $6.9 billion in the 12 months ending January 2009, growing at a rate of 9.9%. Cipla held the largest market share of 5.3% while growing at 13.4%, and Ranbaxy was the second largest with a 5% market share and 11.5% growth rate. By 2010, Ranbaxy had become the largest pharmaceutical company in India with revenues of $41.989 billion, followed by Dr. Reddy's Laboratories with $41.622 billion in revenues.

    Original Description:

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The Indian pharmaceutical market was worth $6.9 billion in the 12 months ending January 2009, growing at a rate of 9.9%. Cipla held the largest market share of 5.3% while growing at 13.4%, and Ranbaxy was the second largest with a 5% market share and 11.5% growth rate. By 2010, Ranbaxy had become the largest pharmaceutical company in India with revenues of $41.989 billion, followed by Dr. Reddy's Laboratories with $41.622 billion in revenues.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    19 views2 pages

    Pharma Data

    Uploaded by

    Gem Emerald
    The Indian pharmaceutical market was worth $6.9 billion in the 12 months ending January 2009, growing at a rate of 9.9%. Cipla held the largest market share of 5.3% while growing at 13.4%, and Ranbaxy was the second largest with a 5% market share and 11.5% growth rate. By 2010, Ranbaxy had become the largest pharmaceutical company in India with revenues of $41.989 billion, followed by Dr. Reddy's Laboratories with $41.622 billion in revenues.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 2

    India's Domestic Pharmaceutical Market (12 Months Ended January 2009)

    Company Size ($ Billion) Market Share (%) Growth Rate (%)


    Total Pharma Market 6.9 100.0 9.9
    Cipla .36 5.3 13.4
    Ranbaxy .34 5.0 11.5
    Glaxo Smithkline .29 4.3 -1.2
    Piramal Healthcare .27 3.9 11.7
    Zydus Cadila .24 3.6 6.8
    Source: ORG IMS

    Top 10 Pharmaceuticals in India, as of 2010

    Ran Revenue Revenue


    Company
    k 2010(Rs crore) 2010(Rs billion)

    1 Ranbaxy Laboratories 4,198.96 41.989

    2 Dr. Reddy's Laboratories 4,162.25 41.622

    3 Cipla 3,763.72 37.637

    4 Sun Pharmaceutical 2,463.59 24.635

    5 Lupin Ltd 2,215.52 22.155

    6 Aurobindo Pharma 2,081.19 20.801

    7 GlaxoSmithKline 1,773.41 17.734

    8 Cadila Healthcare 1,613 16.13


    9 Aventis Pharma 983.80 9.838

    10 Ipca Laboratories 980.44 9.8044

    You might also like